TIMP2 and Nephropathy: Further, in contrast to recently developed damage biomarkers such as TIMP2•IGFBP7, suPAR’s direct pathophysiological involvement and long-lasting kinetics provide robust, longitudinal information on the activity of kidney tissue inflammation, kidney damage, and prognosis in SI-AKI.